Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Astrazeneca (AZN) Share Price

Price 12,546.00p on 28-10-2025 at 06:00:01
Change 0.00p 0%
Buy 12,900.00p
Sell 12,400.00p
Last Trade: Unknown 197.00 at 12,491.42002p
Day's Volume: 0
Last Close: 12,546.00p
Open: 0.00p
ISIN: GB0009895292
Day's Range 0.00p - 0.00p
52wk Range: 9,574.00p - 12,972.00p
Market Capitalisation: £194.50b
VWAP: 0.00p
Shares in Issue: 1.55b

Astrazeneca (AZN) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Unknown* 197 12,491.42002p Currency Conversion
Negotiated Trade
OTC Trade
17:33:16 - 27-Oct-25
Buy* 50,000 12,546.00p SI Trade
16:58:56 - 27-Oct-25
Unknown* 50,000 12,564.85297p Currency Conversion
OTC Trade
16:55:12 - 27-Oct-25
Buy* 834 12,528.90p SI Trade
Negotiated Trade
16:52:02 - 27-Oct-25
Buy* 174 12,528.90p SI Trade
Negotiated Trade
16:52:02 - 27-Oct-25
Buy* 4,314 12,528.90p SI Trade
Negotiated Trade
16:52:02 - 27-Oct-25
Buy* 2,332 12,528.90p SI Trade
Negotiated Trade
16:52:01 - 27-Oct-25
Buy* 12,149 12,528.90p SI Trade
Negotiated Trade
16:52:01 - 27-Oct-25
Buy* 1,078 12,528.90p SI Trade
Negotiated Trade
16:52:01 - 27-Oct-25
Buy* 14,939 12,528.90p SI Trade
Negotiated Trade
16:52:01 - 27-Oct-25
See more Astrazeneca trades

Astrazeneca (AZN) Share Price History

Time period:
to
Date Open High Low Close Volume
28th Oct 2025 (Tue) 12,546.00 12,546.00 12,546.00 12,546.00 0
27th Oct 2025 (Mon) 12,530.00 12,616.00 12,446.00 12,546.00 1,464,674
24th Oct 2025 (Fri) 12,530.00 12,582.00 12,418.00 12,532.00 1,528,688
23rd Oct 2025 (Thu) 12,432.00 12,566.00 12,432.00 12,496.00 1,297,487
22nd Oct 2025 (Wed) 12,398.00 12,628.00 12,382.00 12,540.00 4,968,617
21st Oct 2025 (Tue) 12,468.00 12,550.00 12,442.00 12,474.00 1,399,159
20th Oct 2025 (Mon) 12,668.00 12,712.00 12,564.00 12,564.00 1,245,234
17th Oct 2025 (Fri) 12,522.00 12,574.00 12,362.00 12,558.00 1,792,038
16th Oct 2025 (Thu) 12,456.00 12,610.00 12,366.00 12,554.00 1,378,035
15th Oct 2025 (Wed) 12,684.00 12,700.00 12,434.00 12,644.00 1,646,096
14th Oct 2025 (Tue) 12,724.00 12,808.00 12,642.00 12,738.00 2,583,056
13th Oct 2025 (Mon) 12,830.00 12,908.00 12,610.00 12,724.00 1,233,495
10th Oct 2025 (Fri) 12,794.00 12,926.00 12,758.00 12,782.00 4,525,352
9th Oct 2025 (Thu) 12,744.00 12,940.00 12,740.00 12,940.00 2,356,089
8th Oct 2025 (Wed) 12,806.00 12,972.00 12,776.00 12,806.00 2,932,192
7th Oct 2025 (Tue) 12,700.00 12,830.00 12,676.00 12,780.00 1,597,144
6th Oct 2025 (Mon) 12,716.00 12,866.00 12,687.00 12,726.00 2,970,312
3rd Oct 2025 (Fri) 12,452.00 12,650.00 12,412.00 12,650.00 2,234,256
2nd Oct 2025 (Thu) 12,720.00 12,750.00 12,356.00 12,454.00 3,205,033
1st Oct 2025 (Wed) 11,488.00 12,462.00 11,476.00 12,436.00 4,371,301
30th Sep 2025 (Tue) 11,034.00 11,258.00 10,922.00 11,182.00 2,361,402
29th Sep 2025 (Mon) 11,050.00 11,186.00 10,976.00 11,088.00 2,264,454
See more Astrazeneca price history

Astrazeneca (AZN) Share News

UK shareholder meetings calendar - next 7 days

27th Oct 2025 14:26

Read More

LONDON BROKER RATINGS: Jefferies raises GSK and AstraZeneca to 'buy'

27th Oct 2025 09:45

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

AstraZeneca hails EU approval of Tezspire for rhinosinusitis form

22nd Oct 2025 09:53

(Alliance News) - AstraZeneca PLC on Wednesday said its drug Tezspire has been approved in the European Union for the treatment of adult patients with chronic rhinosinusitis with nasal polyps. Read More

LONDON BROKER RATINGS: Goldman raises IAG; Peel Hunt raises XP Power

22nd Oct 2025 09:42

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and on Tuesday: Read More

AstraZeneca hails US FDA approval for Tezspire for rhinosinusitis form

20th Oct 2025 08:49

(Alliance News) - AstraZeneca PLC on Monday said its lupus drug Saphnelo received a positive opinion from the European Medicines Agency's committee for medicinal products for human use for a new subcutaneous formulation. Read More

See more Astrazeneca news
FTSE 100 Latest
Value9,653.82
Change0.00

Login to your account

Forgot Password?

Not Registered